1 – 10 of 55
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- FRMD6 has tumor suppressor functions in prostate cancer (
- 2019
- The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor (
- Premature activation of Cdk1 leads to mitotic events in S phase and embryonic lethality (
- 2016
- Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML (
- Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer (
- 2015
- Targeting of nucleotide-binding proteins by HAMLET-a conserved tumor cell death mechanism. (
- The activation loop tyrosine 823 is essential for the transforming capacity of the c-Kit oncogenic mutant D816V. (
- TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer. (
- Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells. (
- 2014
- The PI3-kinase isoform p110δ is essential for cell transformation induced by the D816V mutant of c-Kit in a lipid-kinase-independent manner. (